Sponsor Pipeline

Cellenkos, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07499102 CK0801 for Treatment of Aplastic Anemia Aplastic Anemia Not Yet Recruiting
Phase 1/2
NCT07576699 CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD) Steroid Refractory Graft Versus Host Disease Not Yet Recruiting
Phase 1
NCT05423691 Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs Myelofibrosis Recruiting
NCT05695521 Regulatory T Cells for Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis Active, Not Recruiting
NCT03773393 A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome… Bone Marrow Disease Active, Not Recruiting
Disease Areas
Myelofibrosis (1) ALS (1)
Get alerts when Cellenkos, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free